Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?

Overview of attention for article published in BMC Medicine, February 2012

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 86,911 followers.

RT @bmcmedicine: Rudenko et al review treatment for LRRK2-associated #Parkinsonsdisease http://t.co/qkeaZWyP

Rudenko et al review treatment for LRRK2-associated #Parkinsonsdisease focusing on both kinase & non-kinase therapies http://t.co/fqo600eo

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.